New

Implantable Ventricular Assist Devices Market

2021

Implantable Ventricular Assist Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BiVAD), Total Artificial Heart (TAH)); Application (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Other Therapies)

| Report Code: TIPRE00013721 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Implantable Ventricular Assist Devices Market 2028 By Product, Application | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Implantable ventricular assist devices are mechanical pumps that control and regulate the blood flow from ventricles of heart to the rest of body. These devices replicate the functioning of ventricles and implanted at the lower end of heart. These devices are implanted when ventricles fail to perform their function due to various medical conditions such as bundle branch block, and myocardial infection. They are either implanted for small period or lifelong to treat the heart rate. In addition, they are also used as temporary implants until the heart transplant is performed.

MARKET DYNAMICS

The implantable ventricular assist devices market is driving due to the increasing prevalence of cardiovascular disorders, mainly hypertension, ventricular septal defect, heart failure, and stroke. However, risk associated with its implantation such as development of blood clots, respiratory failure and device failure is expected to hamper the growth of the global implantable ventricular assist devices market. Moreover, technological advancements with regard to the advanced features such as infection control technology is anticipated to drive demand the growth of the market.

MARKET SCOPE

The "Implantable Ventricular Assist Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of implantable ventricular assist devices market with detailed market segmentation by product and application. The implantable ventricular assist devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in implantable ventricular assist devices market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The implantable ventricular assist devices market is segmented on the basis of product, and application. On the basis of product, the market is segmented into left ventricular assist device (LVAD), right ventricular assist device (RVAD), biventricular assist device (BiVAD), and total artificial heart (TAH). Based on application, the market is segmented into bridge-to-transplant (BTT) therapy, destination therapy, and other therapies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the implantable ventricular assist devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The implantable ventricular assist devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting implantable ventricular assist devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the implantable ventricular assist devices market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the implantable ventricular assist devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from implantable ventricular assist devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for implantable ventricular assist devices market in the global market. Below mentioned is the list of few companies engaged in the implantable ventricular assist devices market.
The report also includes the profiles of key players in implantable ventricular assist devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   ABIOMED
  •   BiVACOR Inc.
  •   Abbott
  •   Medtronic
  •   Terumo Europe NV
  •   Berlin Heart GmbH
  •   Calon Cardio
  •   Jarvik Heart Inc.
  •   SynCardia Systems LLC
  •   Medtronic

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Implantable Ventricular Assist Devices Market - By Product
1.3.2 Implantable Ventricular Assist Devices Market - By Application
1.3.3 Implantable Ventricular Assist Devices Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. IMPLANTABLE VENTRICULAR ASSIST DEVICES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. IMPLANTABLE VENTRICULAR ASSIST DEVICES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. IMPLANTABLE VENTRICULAR ASSIST DEVICES MARKET - GLOBAL MARKET ANALYSIS
6.1. IMPLANTABLE VENTRICULAR ASSIST DEVICES - GLOBAL MARKET OVERVIEW
6.2. IMPLANTABLE VENTRICULAR ASSIST DEVICES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. IMPLANTABLE VENTRICULAR ASSIST DEVICES MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. LEFT VENTRICULAR ASSIST DEVICE (LVAD)
7.3.1. Overview
7.3.2. Left Ventricular Assist Device (LVAD) Market Forecast and Analysis
7.4. RIGHT VENTRICULAR ASSIST DEVICE (RVAD)
7.4.1. Overview
7.4.2. Right Ventricular Assist Device (RVAD) Market Forecast and Analysis
7.5. BIVENTRICULAR ASSIST DEVICE (BIVAD)
7.5.1. Overview
7.5.2. Biventricular Assist Device (BiVAD) Market Forecast and Analysis
7.6. TOTAL ARTIFICIAL HEART (TAH).
7.6.1. Overview
7.6.2. Total Artificial Heart (TAH). Market Forecast and Analysis
8. IMPLANTABLE VENTRICULAR ASSIST DEVICES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BRIDGE-TO-TRANSPLANT (BTT) THERAPY
8.3.1. Overview
8.3.2. Bridge-To-Transplant (BTT) Therapy Market Forecast and Analysis
8.4. DESTINATION THERAPY
8.4.1. Overview
8.4.2. Destination Therapy Market Forecast and Analysis
8.5. OTHER THERAPIES.
8.5.1. Overview
8.5.2. Other Therapies. Market Forecast and Analysis
9. IMPLANTABLE VENTRICULAR ASSIST DEVICES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Implantable Ventricular Assist Devices Market Overview
9.1.2 North America Implantable Ventricular Assist Devices Market Forecasts and Analysis
9.1.3 North America Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Product
9.1.4 North America Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Application
9.1.5 North America Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Countries
9.1.5.1 United States Implantable Ventricular Assist Devices Market
9.1.5.1.1 United States Implantable Ventricular Assist Devices Market by Product
9.1.5.1.2 United States Implantable Ventricular Assist Devices Market by Application
9.1.5.2 Canada Implantable Ventricular Assist Devices Market
9.1.5.2.1 Canada Implantable Ventricular Assist Devices Market by Product
9.1.5.2.2 Canada Implantable Ventricular Assist Devices Market by Application
9.1.5.3 Mexico Implantable Ventricular Assist Devices Market
9.1.5.3.1 Mexico Implantable Ventricular Assist Devices Market by Product
9.1.5.3.2 Mexico Implantable Ventricular Assist Devices Market by Application
9.2. EUROPE
9.2.1 Europe Implantable Ventricular Assist Devices Market Overview
9.2.2 Europe Implantable Ventricular Assist Devices Market Forecasts and Analysis
9.2.3 Europe Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Product
9.2.4 Europe Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Application
9.2.5 Europe Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Implantable Ventricular Assist Devices Market
9.2.5.1.1 Germany Implantable Ventricular Assist Devices Market by Product
9.2.5.1.2 Germany Implantable Ventricular Assist Devices Market by Application
9.2.5.2 France Implantable Ventricular Assist Devices Market
9.2.5.2.1 France Implantable Ventricular Assist Devices Market by Product
9.2.5.2.2 France Implantable Ventricular Assist Devices Market by Application
9.2.5.3 Italy Implantable Ventricular Assist Devices Market
9.2.5.3.1 Italy Implantable Ventricular Assist Devices Market by Product
9.2.5.3.2 Italy Implantable Ventricular Assist Devices Market by Application
9.2.5.4 Spain Implantable Ventricular Assist Devices Market
9.2.5.4.1 Spain Implantable Ventricular Assist Devices Market by Product
9.2.5.4.2 Spain Implantable Ventricular Assist Devices Market by Application
9.2.5.5 United Kingdom Implantable Ventricular Assist Devices Market
9.2.5.5.1 United Kingdom Implantable Ventricular Assist Devices Market by Product
9.2.5.5.2 United Kingdom Implantable Ventricular Assist Devices Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Implantable Ventricular Assist Devices Market Overview
9.3.2 Asia-Pacific Implantable Ventricular Assist Devices Market Forecasts and Analysis
9.3.3 Asia-Pacific Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Implantable Ventricular Assist Devices Market
9.3.5.1.1 Australia Implantable Ventricular Assist Devices Market by Product
9.3.5.1.2 Australia Implantable Ventricular Assist Devices Market by Application
9.3.5.2 China Implantable Ventricular Assist Devices Market
9.3.5.2.1 China Implantable Ventricular Assist Devices Market by Product
9.3.5.2.2 China Implantable Ventricular Assist Devices Market by Application
9.3.5.3 India Implantable Ventricular Assist Devices Market
9.3.5.3.1 India Implantable Ventricular Assist Devices Market by Product
9.3.5.3.2 India Implantable Ventricular Assist Devices Market by Application
9.3.5.4 Japan Implantable Ventricular Assist Devices Market
9.3.5.4.1 Japan Implantable Ventricular Assist Devices Market by Product
9.3.5.4.2 Japan Implantable Ventricular Assist Devices Market by Application
9.3.5.5 South Korea Implantable Ventricular Assist Devices Market
9.3.5.5.1 South Korea Implantable Ventricular Assist Devices Market by Product
9.3.5.5.2 South Korea Implantable Ventricular Assist Devices Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Implantable Ventricular Assist Devices Market Overview
9.4.2 Middle East and Africa Implantable Ventricular Assist Devices Market Forecasts and Analysis
9.4.3 Middle East and Africa Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Implantable Ventricular Assist Devices Market
9.4.5.1.1 South Africa Implantable Ventricular Assist Devices Market by Product
9.4.5.1.2 South Africa Implantable Ventricular Assist Devices Market by Application
9.4.5.2 Saudi Arabia Implantable Ventricular Assist Devices Market
9.4.5.2.1 Saudi Arabia Implantable Ventricular Assist Devices Market by Product
9.4.5.2.2 Saudi Arabia Implantable Ventricular Assist Devices Market by Application
9.4.5.3 U.A.E Implantable Ventricular Assist Devices Market
9.4.5.3.1 U.A.E Implantable Ventricular Assist Devices Market by Product
9.4.5.3.2 U.A.E Implantable Ventricular Assist Devices Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Implantable Ventricular Assist Devices Market Overview
9.5.2 South and Central America Implantable Ventricular Assist Devices Market Forecasts and Analysis
9.5.3 South and Central America Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Product
9.5.4 South and Central America Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Application
9.5.5 South and Central America Implantable Ventricular Assist Devices Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Implantable Ventricular Assist Devices Market
9.5.5.1.1 Brazil Implantable Ventricular Assist Devices Market by Product
9.5.5.1.2 Brazil Implantable Ventricular Assist Devices Market by Application
9.5.5.2 Argentina Implantable Ventricular Assist Devices Market
9.5.5.2.1 Argentina Implantable Ventricular Assist Devices Market by Product
9.5.5.2.2 Argentina Implantable Ventricular Assist Devices Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL IMPLANTABLE VENTRICULAR ASSIST DEVICES MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. IMPLANTABLE VENTRICULAR ASSIST DEVICES MARKET, KEY COMPANY PROFILES
12.1. ABIOMED
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIVACOR INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABBOTT
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MEDTRONIC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. TERUMO EUROPE NV
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BERLIN HEART GMBH
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CALON CARDIO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. JARVIK HEART INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SYNCARDIA SYSTEMS LLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MEDTRONIC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. ABIOMED
2. BiVACOR Inc.
3. Abbott
4. Medtronic
5. Terumo Europe NV
6. Berlin Heart GmbH
7. Calon Cardio
8. Jarvik Heart Inc.
9. SynCardia Systems LLC
10. Medtronic
TIPRE00013721
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.